Ribociclib in HR+/HER2− Advanced or Metastatic Breast Cancer PatientsKaitlin Rascon, Ekim Ekinci, Meghana V. Trivedi et al.|Annals of Pharmacotherapy|2018Cited by 22
Interactions between ADGRF1 (GPR110) and extracellular matrix proteins govern its effects on tumorigenesis in HER2‐positive breast cancerNoor Mazin Abdulkareem, Meghana V. Trivedi, Raksha R. Bhat et al.|British Journal of Pharmacology|2025Cited by 6